Benitec Biopharma Enters Material Definitive Agreement
Ticker: BNTC · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1808898
| Field | Detail |
|---|---|
| Company | Benitec Biopharma INC. (BNTC) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Benitec Biopharma signed a big deal, filing an 8-K on 3/26/25.
AI Summary
On March 26, 2025, Benitec Biopharma Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Hayward, California, filed this 8-K report with the SEC. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a significant new contract or partnership for Benitec Biopharma, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks depending on the nature of the agreement, which is not detailed in this summary.
Key Numbers
- 20250326 — Report Date (The earliest event reported in this 8-K filing.)
- 20250327 — Filing Date (The date the 8-K was officially filed with the SEC.)
Key Players & Entities
- Benitec Biopharma Inc. (company) — Registrant
- March 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Hayward, California (location) — Principal Executive Offices
- 001-39267 (identifier) — Commission File Number
FAQ
What is the nature of the material definitive agreement Benitec Biopharma Inc. entered into?
The filing states that Benitec Biopharma Inc. entered into a material definitive agreement on March 26, 2025, but the specific details of this agreement are not provided in the summary information.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on March 27, 2025.
What is Benitec Biopharma Inc.'s state of incorporation?
Benitec Biopharma Inc. is incorporated in Delaware.
Where are Benitec Biopharma Inc.'s principal executive offices located?
Benitec Biopharma Inc.'s principal executive offices are located at 3940 Trust Way, Hayward, California.
What is the Commission File Number for Benitec Biopharma Inc.?
The Commission File Number for Benitec Biopharma Inc. is 001-39267.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Benitec Biopharma Inc. (BNTC).